Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  ResApp Health Limited    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 11/26
0.09 AUD   -1.10%
04/05RESAPP HEALTH : Morgans rates RAP as Add
AQ
2019RESAPP HEALTH : 2019 Letter to Shareholders
PU
2017RESAPP HEALTH : Updated Corporate Governance Policies
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

ResApp Health : 2019 Letter to Shareholders

11/24/2019 | 05:38pm EST

Access to this site

Your access to the site constitutes your agreement to be bound by the General Conditions which are available at http://www.asx.com.au/legal/general_conditions.htm.

Real time company announcements are freely available on our site for investors' private and personal use. A distinction is drawn however where use is for a 'commercial' as opposed to 'private or personal' purpose. Should you wish to access and use this information for a commercial purpose, the express written authority of ASX is required.

Professional or commercial use would include use by any person that falls into the following categories:

  • You are seeking to access and use the information other than for private or personal investment purposes.
  • You are seeking to access and use the information in connection with any trade or business.
  • You are engaged in the business of accessing or aggregating information and redistributing or otherwise furnishing that information to third parties.
  • You are a member or participating organisation of an exchange or an approved representative or other employee of such an organisation accessing and using the information in connection with your employment, or any associated person of the foregoing.
  • You are employed by a bank, insurance company, fund or asset manager or other organisation to perform functions related to trading or investment in financial products and you are accessing and using the information in connection with your employment.

If you are unsure as to whether you come within one of the above categories, please email your query to info@asx.com.au.

ASX provides ASX ComNews and ASX ComNews Direct with additional features to support professional investors and other commercial activities. Further information on these products can be obtained by emailing info@asx.com.au.

Company announcements and related materials made available through this site may contain embedded hyperlinks to external websites operated by third parties or their licensees or contractors ('Third Party Websites'). Third Party Websites are not under the control of ASX, and ASX is not responsible for the content of any Third Party Website. ASX does not endorse, sponsor or approve of any of the products or services provided through the Third Party Websites, or the owners or operators of such Third Party Websites. ASX does not represent or warrant the quality, reliability, accuracy or completeness of any content of the Third Party Websites, nor does ASX represent or warrant that any Third Party Website will be free of computer viruses or other conditions which could damage or interfere with your computer system, data or software. Neither ASX nor its directors, officers, agents, employees or contractors will be liable for any loss or damage arising in any way (including negligence) from or in connection with your access to and use of a Third Party Website and any such access or use is done solely at your own risk.

I confirm that any content I access will not be used for any commercial purpose in the context as explained above, without the express written authority of ASX.

Disclaimer

ResApp Health Limited published this content on 25 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2019 22:37:03 UTC


© Publicnow 2019
All news about RESAPP HEALTH LIMITED
04/05RESAPP HEALTH : Morgans rates RAP as Add
AQ
2019RESAPP HEALTH : 2019 Letter to Shareholders
PU
2017RESAPP HEALTH : Updated Corporate Governance Policies
PU
2017RESAPP HEALTH (ASX : RAP) talks study results and clinical trials
FI
2017RESAPP HEALTH : Update on Field Evaluation by Médecins Sans Frontières/Doctors W..
PU
2017RESAPP HEALTH : Update on Field Evaluation by Medecins Sans Frontieres
PU
2017RESAPP HEALTH : SMARTCOUGH-C Study and Paediatric Clinical Strategy Update
PU
2017RESAPP HEALTH : Appendix 4E - Preliminary Final Report
PU
2017RESAPP HEALTH : Dr Philip Currie Joins ResApp's Scientific Advisory Board
PU
2017RESAPP HEALTH : Dr Philip Currie Joins ResApp's Scientific Advisory Board
PU
More news
Financials
Sales 2021 2,40 M 1,78 M 1,78 M
Net income 2021 -4,90 M -3,63 M -3,63 M
Net cash 2021 3,10 M 2,29 M 2,29 M
P/E ratio 2021 -15,3x
Yield 2021 -
Capitalization 69,7 M 51,6 M 51,6 M
EV / Sales 2021 27,8x
EV / Sales 2022 5,53x
Nbr of Employees -
Free-Float 85,9%
Chart RESAPP HEALTH LIMITED
Duration : Period :
ResApp Health Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESAPP HEALTH LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 0,21 AUD
Last Close Price 0,09 AUD
Spread / Highest target 128%
Spread / Average Target 128%
Spread / Lowest Target 128%
EPS Revisions
Managers
NameTitle
Tony Keating Chief Executive Officer, Executive Director & MD
Roger Aston Non-Executive Chairman
Udantha Abeyratne Chief Scientist
Rob Keniger Vice President-Technology
Christopher Ntoumenopoulos Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
RESAPP HEALTH LIMITED-63.27%52
FAIR ISAAC CORPORATION26.93%13 779
SOLARWINDS CORPORATION23.61%7 201
Q2 HOLDINGS, INC.41.96%6 202
THE DESCARTES SYSTEMS GROUP INC36.50%4 931
KINAXIS INC.88.06%3 906